| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Copyright
|
|
|
|
12 |
S1 |
p. iv
|
artikel
|
| 2 |
Current use of HER2 tests
|
Schaller, G.
|
|
|
12 |
S1 |
p. S97-S100
|
artikel
|
| 3 |
Editorial board
|
|
|
|
12 |
S1 |
p. iv
|
artikel
|
| 4 |
Future directions in the adjuvant treatment of breast cancer: The role of trastuzumab
|
Smith, I.
|
|
|
12 |
S1 |
p. S75-S79
|
artikel
|
| 5 |
HER2 – a discussion of testing approaches in the USA
|
Thor, A.
|
|
|
12 |
S1 |
p. S101-S107
|
artikel
|
| 6 |
HER2 as a prognostic and predictive marker for breast cancer
|
Cooke, T.
|
|
|
12 |
S1 |
p. S23-S28
|
artikel
|
| 7 |
HER2 overexpression in various tumor types, focussing on its relationship to the development of invasive breast cancer
|
Ménard, S.
|
|
|
12 |
S1 |
p. S15-S19
|
artikel
|
| 8 |
HER2 status: A statistician’s view
|
Valagussa, P.
|
|
|
12 |
S1 |
p. S29-S34
|
artikel
|
| 9 |
Introduction
|
Piccart, M.
|
|
|
12 |
S1 |
p. S1
|
artikel
|
| 10 |
Mechanism of action of anti-HER2 monoclonal antibodies
|
Baselga, J.
|
|
|
12 |
S1 |
p. S35-S41
|
artikel
|
| 11 |
Modulation of p27/Cdk2 complex formation through 4D5-mediated inhibition of HER2 receptor signaling
|
Lane, H.A.
|
|
|
12 |
S1 |
p. S21-S22
|
artikel
|
| 12 |
Ongoing trials with trastuzumab in metastatic breast cancer
|
Bell, R.
|
|
|
12 |
S1 |
p. S69-S73
|
artikel
|
| 13 |
Pharmacologic insights into the future of trastuzumab
|
Leyland-Jones, B.
|
|
|
12 |
S1 |
p. S43-S47
|
artikel
|
| 14 |
Phase I and II clinical trials of trastuzumab
|
Baselga, J.
|
|
|
12 |
S1 |
p. S49-S55
|
artikel
|
| 15 |
Proposed treatment guidelines for HER2-positive metastatic breast cancer in Europe
|
Piccart, M.J.
|
|
|
12 |
S1 |
p. S89-S94
|
artikel
|
| 16 |
Table of Contents
|
|
|
|
12 |
S1 |
p. iii
|
artikel
|
| 17 |
Targeting HER2 in other tumor types
|
Scholl, S.
|
|
|
12 |
S1 |
p. S81-S87
|
artikel
|
| 18 |
The basic biology of HER2
|
Rubin, I.
|
|
|
12 |
S1 |
p. S3-S8
|
artikel
|
| 19 |
The role of overexpressed HER2 in transformation
|
Neve, R.M.
|
|
|
12 |
S1 |
p. S9-S13
|
artikel
|
| 20 |
Title Page
|
|
|
|
12 |
S1 |
p. ii
|
artikel
|
| 21 |
Tolerability in patients receiving trastuzumab with or without chemotherapy
|
Gianni, L.
|
|
|
12 |
S1 |
p. S63-S68
|
artikel
|
| 22 |
Trastuzumab combined with chemotherapy for the treatment of HER2-positive metastatic breast cancer: Pivotal trial data
|
Eiermann, W.
|
|
|
12 |
S1 |
p. S57-S62
|
artikel
|
| 23 |
Trastuzumab in the treatment of advanced breast cancer: Single-center experience
|
Mrsić, M.
|
|
|
12 |
S1 |
p. S95-S96
|
artikel
|
Tijdschrift beschrijving